Syndetics omslagsbild
Bild från Syndetics

Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition

Av: Medverkande: Materialtyp: ArtikelUtgivningsinformation: MDPI - Multidisciplinary Digital Publishing Institute 2025Beskrivning: 1 electronic resource (282 p.)Innehållstyp:
  • text
Medietyp:
  • computer
Bärartyp:
  • online resource
ISBN:
  • 9783725840274
  • 9783725840281
Ämnen: Onlineresurser: Sammanfattning: This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6″-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development.
Inga fysiska exemplar för denna post

Open Access Unrestricted online access star

This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6″-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development.

Creative Commons Licence cc by cc https://creativecommons.org/licenses/by/4.0/

eng

Freely available e-book